Rationale: Autologous stem cell therapy using human c-Kit + cardiac progenitor cells (hCPCs) is a promising therapeutic approach for treatment of heart failure (HF). However, hCPCs derived from aged patients with HF with genetic predispositions and comorbidities of chronic diseases exhibit poor proliferative and migratory capabilities, which impair overall reparative potential for injured myocardium. Therefore, empowering functionally compromised hCPCs with proregenerative molecules ex vivo is crucial for improving the therapeutic outcome in patients with HF. 
H eart failure (HF) secondary to cardiomyopathy is a leading cause of death in the US and worldwide, necessitating developing alternative therapeutic strategies to tackle the progression of HF and alleviate its symptoms. Autologous stem cell therapy has been implemented as a promising therapeutic approach for HF for over a decade. c-Kit + cardiac-derived progenitor cells (CPCs) improve cardiac function after myocardial infarction in animal models. 1, 2 In comparison, adoptive transfer of autologous c-Kit + CPCs into patients with pathologically injured myocardium yields modest and more variable outcomes in clinical trials. 3, 4 Inconsistent findings in the clinical setting are likely due, at least in part, to severely compromised regenerative potential of stem cells isolated from patients with HF with genetic predispositions, comorbidities of chronic diseases, such as hypertension and diabetes mellitus, and daily life stressors, such as smoking and alcoholism. Therefore, enhancing regenerative capacity of stem cells ex vivo before transplantation is an interventional strategy to improve outcome of stem cell therapy as exemplified by empowering stem cells from diverse origins with prosurvival and antiapoptotic genes. 5, 6 Regenerative capacity of stem cells also depends on their ability to communicate with and adapt to the extracellular environment. To date, molecular mechanisms by which stem cells detect stress signals to initiate regenerative responses are poorly understood. Extracellular nucleotides represent a major class of stress signals that accumulate in the extracellular milieu in response to injury/stress. Extracellular nucleotides bind to and activate transmembrane purinergic receptors that are categorized into P1 receptors (activated by adenosine) and P2 receptors (activated by ATP, ADP, UTP, UDP, and UDP sugars). P2 receptors comprise 7 P2X ligand-gated ion channels (P2X1-7) and 8 P2Y G protein-coupled receptors (P2Y 1, 2, 4, 6, 11, 12, 13, 14 ) . 7, 8 Whereas some P2 receptors initiate early inflammatory responses, others mediate later regenerative responses required for the healing process.
P2Y 2 nucleotide receptor (P2Y 2 R) is a proregenerative Gαq protein-coupled receptor activated by ATP and UTP, which are released during cardiac ischemia. [9] [10] [11] [12] P2Y 2 R plays a central role in intracellular signaling by enabling extracellular ATP and UTP to promote regenerative responses in a variety of tissues. P2Y 2 R regulates corneal epithelia wound healing 13 and salivary gland reconstitution 14 by inducing cell migration, liver regeneration by promoting hepatocyte proliferation, 15 and reepithelialization after experimental colitis 16 and inflammatory bowel disease. 17 On the stem cell level, UTP is a potent stimulant of human hematopoietic stem cell migration. 18 Herein, we hypothesize that P2Y 2 R induces proliferative and migratory responses in functionally compromised human CPCs (hCPCs) derived from patients with HF.
Gαq protein-coupled signaling regulates cell proliferation and migration through activation of YAP (yes-associated protein)-the downstream effector of Hippo signaling. 19 However, it is not known whether Gαq protein-coupled P2Y 2 R-induced proliferative and migratory responses are dependent on YAP activation ( Figure 1 ). YAP activity is tightly regulated by multiple upstream kinases, including mammalian MST1 (Hippo homolog) and LATS1 (large tumor suppressor kinase 1). 20 MST1 activates LATS1, which in turn phosphorylates and represses YAP activity by promoting cytoplasmic retention. Conversely, LATS1 inhibition leads to YAP dephosphorylation (activation) and shuttling into the nucleus where it acts as a transcriptional coactivator to induce expression of genes that promote cell proliferation, migration, and survival. 20 Given the importance of purinergic signaling in stress responses and sensing environmental damage, phenotypic associations should be present between growth potential of hCPCs derived from patients with HF and P2 purinergic receptor expression. Indeed, expression of select P2 receptors, including the proregenerative P2Y 2 R, directly correlated with hCPC growth kinetics. Proliferation and migration of functionally compromised hCPCs were improved by P2Y 2 R activation or overexpression and impaired by P2Y 2 R knockdown. P2Y 2 Rinduced proliferation and migration were mediated by YAP activation, introducing a novel downstream component in the P2Y 2 R intracellular signaling cascade. These findings are discussed in the context of manipulating hCPCs to enhance their phenotypic properties. 
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Methods
Human Cardiac Progenitor Cell Isolation
Human CPCs were isolated from cardiac tissue specimens derived from patients undergoing left ventricular assist device implantation surgeries as described previously. 21 Briefly, tissue was minced, digested in collagenase (150 U mg/mL; Worthington Bio Corp) for 2 hours at 37°C, then incubated with c-Kit-labeled beads (Miltenyi Biotec), and sorted according to the manufacturer's protocol. Pelleted cells were cultured in hCPC growth media: Hams F12 (Fisher Scientific), 10% embryonic stem cell screened fetal bovine serum, 1% penicillin/streptomycin/glutamine, 5 mU/mL human erythropoietin (Sigma-Aldrich), 10 ng/mL basic fibroblast growth factor (Peprotech), and incubated at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. hCPCs with doubling time ≤24 hours were considered as fast growers (F-hCPCs), whereas hCPCs with doubling time >24 hours were considered as slow growers (S-hCPCs).
Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was isolated from hCPCs using Quick-RNA MiniPrep (Zymo Research), and cDNA was synthesized using iScript cDNA Synthesis Kit (Bio Rad) according to manufacturers' protocols. Samples were prepared for quantitative reverse transcriptase-polymerase chain reaction using iQ SYBER Green (Bio Rad). Primer sequences are listed in Online Table I .
Calcium Imaging
Cultured cells on glass-bottom plates grown to 60% to 70% confluency were loaded for 1 hour with the calcium-dependent ratiometric fluorescent dye Fura-2 AM (4 µM) in Krebs-Ringer solution (125 mmol/L NaCl, 5 mmol/L KCl, 1.2 mmol/L Mg 2 SO 4 , 2 mmol/L CaCl 2 , 10 mmol/L glucose, 25 mmol/L HEPES, and pH was adjusted to 7.4 with NaOH). Afterward, cells were washed in Krebs-Ringer solution for 30 minutes to allow for de-esterification of Fura-2 AM dye. Ca 
Cell Proliferation Assay
hCPCs were cultured in serum-starved medium (Hams F12 media supplemented with 2.5% embryonic stem cell screened fetal bovine serum) in a 96-well plate (500 cells/ well) and then treated with CyQuant fluorescent nucleic-acid based dye (Life Technologies) that labels live cells where the fluorescence intensity directly correlates with cell number. After 1 hour, fluorescence intensity was measured using a plate reader and considered as baseline (day 0) reading. Then cells were treated with or without UTP (100 µM), and 24 hours later, CyQuant reagent was added, and day-1 reading was recorded. Population doubling times were calculated based on readings from CyQuant assay using a population doubling time online calculator (http://www.doubling-time.com/compute.php). In inhibitor studies, cells were pretreated with YAP selective inhibitor (verteporfin; 100 nM; Tocris Bioscience) for the indicated times before UTP treatment.
Cell Migration Assay
hCPC single-cell suspensions were seeded in serum-free Hams F12 media in a 96-well plate coated with growth factor reduced Matrigel (BD Biosciences; 1600 cells/well) and incubated at 37°C in a humidified atmosphere of 5% CO 2 and 95% air for 2 hours. Then the cell culture plate was mounted on a DMI6000 live cell imaging microscope (Leica) equipped with a digital camera, an automatic shutter, a motorized x-y stage and an OKO stage top incubator (37°C, 5% CO 2 , and 95% air). A field of cells was located within each well with a 5× objective and marked for monitoring during the duration of the experiment. The exposure time was kept constant for all positions and all time points. Bright field images of cells were obtained every 30 minutes for 6 hours. Cell migration was assessed by measuring distance travelled from origin using Leica LAX software. Cell velocity was calculated by dividing distance travelled from origin over time. In inhibitor studies, cells were pretreated with YAP selective inhibitor (verteporfin; 100 nM; Tocris Bioscience) for the indicated times before UTP treatment.
Protein Isolation, Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis, and Immunoblot Analysis
hCPCs were seeded in a 6-well plate (30 000 cells/well). Next day, cells were treated with or without UTP (100 µM) in serum-starved medium for the indicated times. Samples were collected in 50 μL of sample buffer, sonicated, and boiled. Protein lysates were run on 4% to 12% NuPage Novex Bis Tris gel (Invitrogen), transferred on to a polyvinylidene fluoride membrane, blocked in 5% skim milk in Tris-buffered saline Tween-20 solution for 1 hour at room temperature, then incubated with primary antibodies overnight at 4°C. Membranes were incubated with secondary antibodies (1:1000-1:5000) for 1 hour at room temperature after several washes with Tris-buffered saline Tween-20. Fluorescence signal was detected using Typhoon or LI-COR fluorescent scanners and quantitated using ImageJ software (Amersham Biosciences). Antibodies used are listed in Online Table II .
Nuclear/Cytoplasmic Fractionation
hCPCs were cultured in 100-mm dishes (180 000 cells/well). The following day, cells were treated with or without UTP (100 µM) in serum-starved medium for the indicated times. Preparation of separate nuclear and cytoplasmic lysates was performed using Paris Kit (Thermo Fisher Scientific) according to manufacturer's instructions. Briefly, adherent hCPCs were detached by trypsinizing for 3 to 5 minutes, and then trypsin was inactivated with hCPC growth medium. Cells were pelleted, culture medium was aspirated, cell pellet was gently resuspended in 100-µL ice-cold cell fractionation buffer and incubated on ice for 5 to 10 minutes. Samples were then centrifuged for 5 minutes at 4°C and 500 g. The supernatant (cytoplasmic fraction) was carefully transferred to a new tube. The pellet (nuclear fraction) was washed once with ice-cold cell fractionation buffer and centrifuged for 5 minutes at 4°C and 500 g. Fractionation buffer was aspirated. Sample buffer was added to nuclear pellet, and cytoplasmic fraction and samples were analyzed using sodium dodecyl sulfate polyacrylamide gel electrophoresis followed by immunoblotting as described above. Antibodies used are listed in Online Table II .
Immunocytochemistry
hCPCs were cultured in 2-well chamber slides (15 000 cell/well). Next day, cells were treated with or without UTP (100 µM) in serum-starved medium for the indicated times. Cells were fixed with 4% paraformaldehyde for 10 minutes, washed twice (5 minutes each) with 1X phosphate-buffered saline (PBS), permeabilized with 1% Triton-X-100 for 10 minutes, washed twice (5 minutes each) with 1X PBS, then blocked with 10% horse serum for 45 minutes at 37°C. Then cells were treated with primary antibody in blocking solution (1:100) overnight at 4°C. The following day, cells were washed twice (5 minutes each) with 1X PBS, and then treated with secondary antibody in blocking solution (1:200; Invitrogen) for 1 hour at 37°C. Cells were then washed once (5 minutes) with 1X PBS, treated with the nuclear stain DAPI in 1X PBS (1:10 000; Sigma-Aldrich) for 1 minute. Finally, cells were rinsed in 1X PBS and mounted using VectaShield. Images were acquired in z-stacks using SP8 confocal microscope (Leica), and quantification of nuclear signal intensity was performed on maximum projection of stacked images and normalized to nuclear area. Antibodies used are listed in Online Table II .
Lentiviral-Mediated Transduction of Human CPCs
hCPCs were cultured in a 6-well plate (30 000 cells/well). The following day, hCPCs were transduced with lentivirus (0.2 multiplicity of infection [MOI]) encoding either monomeric green fluorescent protein (hCPC-mGFP) or P2Y 2 R fused to mGFP (hCPC-Y2; lentiviral plasmids were purchased from Origene; SKU: RC223931L2). To knockdown P2Y 2 R, hCPCs were transduced with lentiviral particles encoding P2Y 2 R shRNA and mGFP (20 MOI; lentiviral plasmid was purchased from Origene; SKU: TL302717; Gene identifier: 5029) or scrambled shRNA and enhanced GFP (eGFP; 2 MOI) as a control. 22 
Statistical Analysis
Quantitative results are presented as the means±SE of data from at least 3 experiments. Two-tailed Student t test or ANOVA followed by Dunnett or Bonferroni post hoc test was performed, as indicated, where P <0.05 represents a significant difference. Statistical analysis was performed using GraphPad prism, version 5.0 (GraphPad Software).
Results
Differential P2 Receptor Subset Expression in Fastand Slow-Growing CPCs
hCPCs derived from multiple HF patients exhibit variation in growth rate previously characterized as fast growing (F-hCPC) or slow growing (S-hCPC). 21 F-hCPCs are characterized by a spindly morphology and lower levels of senescence markers, whereas S-hCPCs exhibit a flat morphology associated with higher levels of senescence markers. 21 P2 receptor mRNA expression levels were assessed by quantitative reverse transcriptase-polymerase chain reaction-based analysis in representative fast-and slow-growing hCPC lines (Table) . Receptor mRNA expression was present for P2X4, P2X5, P2X6, P2Y1, P2Y2, P2Y4, P2Y11, and P2Y14 in all hCPC lines examined. However, several P2 receptors were differentially expressed between fast-and slow-growing lines: P2Y1, P2Y2, and P2Y14 were significantly downregulated in S-hCPCs compared with F-hCPCs (0.031±0.015-fold change, P=0.012; 0.22±0.046-fold change, P=0.0112; and 0.058±0.014-fold change, P=0.0014, respectively; Figure 2 ). P2Y 2 R was particularly intriguing based on prior reports of involvement in regeneration using various Figure IA ). P2Y 2 R was also downregulated at the protein level in S-hCPCs compared with F-hCPCs (0.56±0.047-fold change; P=0.0026).
Improving CPC Proliferation and Migration by P2Y 2 R Overexpression
hCPC proliferation and migration potential was improved by increasing P2Y 2 R levels. hCPCs were infected with lentiviral particles encoding P2Y 2 R fused to mGFP (hCPC-Y2) or mGFP alone (hCPC-mGFP) as a control. Figure IIC) . Expression of GFP alone did not alter hCPC proliferation (Online Figure  IID) . P2Y 2 R overexpression improved basal hCPC proliferation (1.47±0.1-fold change; P=0.0031; Figure 3A ; Online Figure IIIA ) and migration indicated by increased distance travelled from origin (1.37±0.14-fold change; P=0.047; Figure 3B ; Online Figure IIIB and IIII). P2Y 2 R overexpression studies were performed in 3 representative lines with varying doubling times (H10-001, 24 hours; H13-073, 31 hours; and H13-064, 41 hours).
P2Y 2 R Overexpression Enhances YAP Activation
YAP-the downstream effector of Hippo signaling pathway-is a critical regulator of proliferation and migratory responses in several experimental models. [26] [27] [28] [29] [30] Although YAP activity is modulated by Gαq protein-coupled receptors, 19 upstream regulatory extracellular signals are still largely unknown. Overexpression of the Gαq protein-coupled P2Y 2 R resulted in significant downregulation of Hippo signaling pathway upstream kinases MST1 (0.67±0.097-fold change; P=0.0419) and LATS1 (0.64±0.055-fold change; P=0.0224). No significant differences were observed on phosphorylated 
cells (CPCs). Expression of (A) P2X4, (B) P2X5, (C) P2X6, (D) P2Y1, (E) P2Y2, (F) P2Y4, (G) P2Y11, and (H) P2Y14
receptor mRNA by reverse transcriptase-polymerase chain reaction analysis in fast-growing human CPCs (F-hCPC) and slow-growing hCPCs (S-hCPC). Cycle numbers were normalized to 18S and data are represented relative to F-hCPC. P2Y1, P2Y2, and P2Y14 mRNA expression levels are significantly downregulated in S-hCPC compared with F-hCPC (n=5-7). *P<0.05 indicates significant difference from F-hCPC as measured by unpaired Student t test. Figure V) . MST1 and LATS1 downregulation was associated with activation of YAP as indicated by reduced phosphorylation at S 127 residue (0.86±0.0097-fold change; P=0.005; Figure 3C through 3F). Total YAP levels were not significantly impacted by P2Y 2 R overexpression ( Figure 3G ). Importantly, expression of GFP alone did not alter basal YAP activity (Online Figure IIE) .
MST1/2 or phosphorylated LATS1 levels (Online
CPC Activation by the P2Y 2 R Agonist UTP
Gαq protein-coupled receptor activation results in calcium release from intracellular stores through phospholipase C/ inositol 1,4,5-trisphosphate signaling pathway. 31 Therefore, Gαq protein-coupled P2Y 2 R function was assessed by measurement of intracellular calcium [Ca 2+ ] i levels in response to ligand stimulation by UTP. Stimulation of hCPCs with UTP enhanced [Ca 2+ ] i levels as indicated by a calcium transient ( Figure 4A ; Online Figure VI) . P2Y 2 R inhibition using the selective antagonist AR-C 118925XX impaired UTP-mediated calcium transients in a dose-dependent manner (0.1 μM, 0.71±0.095-fold change; 1 μM, 0.44±0.14-fold change; 10 μM, 0.12±0.019-fold change; P=0.0005; Figure 4B ), indicating UTP-induced responses are primarily mediated by P2Y 2 R. P2Y 2 R is a potent stimulator of cell proliferation and migration. [13] [14] [15] 32, 33 Consistent with these findings, hCPC stimulation with P2Y 2 R agonist UTP for 24 hours significantly enhanced cell proliferation (1.56±0.073-fold change; P<0.0001; Figure 4C ). Additionally, UTP treatment enhanced hCPC migration on growth factor reduced Matrigel as shown by increased distance travelled from origin (from 47 326±2029 to 67 145±4173 nm; P=0.0001; Figure 4D ) and cell velocity (from 2.21±0.09 to 3.12±0.19 nm/sec; P=0.0001; Figure 4E ). The effect of UTP stimulation on proliferation and migration was assessed in 6 hCPC lines with varying doubling times (Online Figure VII) . UTP signals through 2 P2 receptors: P2Y 2 and P2Y 4 . To validate involvement of P2Y 2 R in UTP-induced responses, P2Y 2 R knockdown was performed in hCPCs using lentivirus encoding P2Y 2 R shRNA or scrambled shRNA as a control. Transduction Figure 3 . Enhancing cardiac progenitor cell (CPC) proliferation, migration, and yes-associated protein (YAP) activation by P2Y 2 R overexpression. A, Proliferation (n=7) and (B) migration (n=6) analysis showing that human CPC (hCPC)-Y2 exhibit enhanced proliferative and migratory capabilities compared with control hCPC-monomeric green fluorescent protein (mGFP). Cell proliferation was measured using CyQuant assay, and cell migration on growth factor reduced Matrigel was assessed by measuring the distance that cells traveled from origin after monitoring by time-lapse live cell imaging for 6 h. hCPC immunoblotting analysis (C) and corresponding quantification (D-G) showing downregulation of YAP repressors MST1 (n=4) and LATS1 (n=5) and decreased YAP S127 phosphorylation (indicating activation; n=4) and no significant change in total YAP levels (n=4) in hCPC-Y2 compared with control hCPC-mGFP. pYAP S127 was normalized to total YAP. Total MST1, LATS1, and YAP levels were normalized to β-actin (loading control). *P<0.05 and **P<0.01 indicate significant difference from hCPC-mGFP as measured by paired Student t test. November 10, 2017 efficiency was assessed by flow cytometry for percentage of GFP + cells (68.23±8.09% for hCPCs using lentivirus encoding P2Y 2 R shRNA and 59±10.48% for hCPCs using scrambled shRNA; Online Figure VIIIA 
UTP Prompts YAP Activation and Nuclear Localization
The role of P2Y 2 R in regulating Hippo signaling was validated via assessment of LATS1 kinase and YAP activity resulting from P2Y 2 R stimulation. hCPC treatment with UTP for 5, 10, or 15 minutes significantly inhibited phosphorylation of Hippo signaling upstream kinase LATS1 compared with untreated control (5 minutes, 0.61±0.1218-fold change; 10 minutes, 0.47±0.06-fold change; 15 minutes, 0.59±0.089-fold change; P=0.0173), whereas total LATS1 levels were unchanged ( Figure 5A and 5C Figure 5B and 5D) resulting from inhibition of upstream kinase LATS1. YAP dephosphorylation leads to activation and shuttling into the nucleus, so YAP nuclear localization was assessed after UTP treatment via immunoblotting on hCPC nuclear extracts. UTP stimulation increased YAP nuclear levels 15 minutes post-treatment (1.97±0.27-fold change; P<0.05; Figure 6A and 6B) as corroborated by confocal analysis showing higher levels of nuclear YAP in response to UTP stimulation for 5 minutes (1.51±0.16-fold change; P<0.05; Figure 6C and 6D). As expected, the phosphorylated inactive form of YAP (pYAP S127 ) was only detected in the cytoplasmic fraction and excluded from the nucleus (Online Figure IX) . Collectively, these findings support P2Y 2 R-mediated YAP activation and nuclear localization through inhibition of upstream YAP repressor LATS1.
In addition, hCPC stimulation with UTP activated ERK1/2 (Online Figure X) -a canonical inducer of cell proliferation and migration 34 that is known to crosstalk with both P2Y 2 R [35] [36] [37] [38] and YAP signaling pathways.
39-42
UTP Enhances Expression of YAP Target Genes
Upon activation, YAP shuttles to the nucleus where it serves as a transcriptional coactivator for induction of gene expression to promote cell proliferation and migration. 20 Expression of canonical YAP target genes after UTP stimulation revealed significantly elevated mRNA levels of CTGF (1.84±0.19-fold change; P<0.05), INHBA (1.47±0.09-fold change; ] i amplitude after hCPC treatment with selective P2Y 2 R inhibitor AR-C 118925XX (0.1, 1, and 10 µM) for 2 h. Data are represented relative to 0 µM P2Y 2 R inhibitor. **P<0.01 and ***P<0.001 indicate significant difference from 0-µM P2Y 2 R inhibitor as measured by 1-way ANOVA followed by Dunnett post hoc test. C, UTP induces hCPC proliferation as assessed by CyQuant assay on hCPCs treated with or without UTP (100 µM) for 24 h (n=32). ***P<0.001 indicates significant difference from control group as measured by paired Student t test. D, hCPC stimulation with UTP increases migration on growth factor reduced Matrigel as assessed by measuring the distance traveled from origin and (E) cell velocity 6 h after UTP (100 µM) treatment. Cell migration was monitored using time-lapse live cell imaging (n=18). ***P<0.001 indicates significant difference from control group as measured by unpaired Student t test. 
UTP-Induced CPC Proliferation and Migration Are Dependent on YAP Activation
Involvement of YAP in UTP-induced proliferation and migration responses in hCPCs was confirmed by pretreatment with the selective YAP inhibitor verteporfin (100 nM) for 1 hour before UTP treatment. A dose response of 1 to 1000 nM of verteporfin was performed, and 100 nM was the minimum dose required to significantly impair UTP-induced proliferation (from 1.43±0.072 to 1.15±0.062-fold change; P<0.05) without altering basal proliferation levels ( Figure 8A ). Verteporfin abolished UTP-induced migration (from 1.57±0.218 to 0.94±0.058-fold change; P<0.05; Figure 8B ; Online Figure  XII) . Therefore, UTP-induced proliferation and migration in hCPCs are YAP-dependent.
Discussion
Autologous stem cell therapy is a promising approach for treatment of HF. However, stem cells derived from patients with HF exhibit impaired proliferative and migratory capabilities, 43 which could be addressed by identifying molecular components regulating these critical phenotypic characteristics of hCPCs. Findings in this study point to P2Y 2 R as an important regulator of hCPC proliferation and migration and delineate underlying mechanisms. P2Y 2 R was significantly downregulated in S-hCPCs compared with fast growers (F-hCPCs). Augmenting P2Y 2 R levels or P2Y 2 R stimulation with UTP in hCPCs efficiently improved proliferation and migration potential. P2Y 2 R-induced responses involved downstream activation of YAP signaling, introducing a novel component into the P2Y 2 R intracellular signaling network.
A primary role of stem cells emerges after injury and subsequent contribution to tissue repair and regeneration. Nucleotides accumulate in the extracellular milieu after injury/stress and activate purinergic receptors to initiate D) showing reduced phosphorylation of LATS1 (indicating inhibition) and YAP S127 (indicating activation) in response to UTP (100 µM) treatment. pLATS1 (n=3-4/time point) and pYAP S127 (n=5-6/time point) were normalized to total LATS1 and total YAP levels, respectively. Total LATS1 (n=8) and total YAP levels (n=4) were normalized to β-actin (loading control). Data are represented relative to 0 min (no UTP treatment). *P<0.05 and **P<0.01 indicate significant difference from 0 min as measured by 1-way ANOVA followed by Dunnett post hoc test. November 10, 2017 physiological responses required for the repair process. 7, 8 Stem cells with compromised ability to detect extracellular nucleotides could elicit impaired regenerative responses to injury. Thus, a major key to improving regenerative capacity of impaired stem cells would be to augment detection of extracellular nucleotides through modulating purinergic receptors. P2Y 2 R endogenous agonists ATP and UTP accumulate in large levels in the extracellular space in response to cellular stress [9] [10] [11] [12] as a signal to prompt cellular reaction to injury. However, P2Y 2 R was significantly downregulated in S-hCPCs isolated from cardiac biopsies of patients with HF ( Figure 2E ). Restoration of P2Y 2 R levels by lentiviral-mediated overexpression augments their proliferative and migratory capabilities (Figure 3) . These results reinforce the emerging view of P2Y 2 R as proproliferative in various experimental models, including hepatocytes, 15, 44 corneal endothelial cells, 45 Figure 6. UTP enhances YAP (yes-associated protein) nuclear localization in cardiac progenitor cells (CPCs). Cytoplasmic and nuclear extracts of human CPCs (hCPCs) on immunoblot (A) with corresponding quantification (B) shows increased nuclear levels of YAP 15 min after UTP (100 µM) stimulation. Cytoplasmic YAP was normalized to β-tubulin, and nuclear YAP was normalized to Lamin A (n=4-6/time point). C, Representative fluorescence microscopy images of hCPCs and (D) corresponding quantification showing increased nuclear levels of YAP 5 min after UTP (100 µM) treatment (n=3). YAP nuclear signal intensity was normalized to nuclear area. DAPI nuclear stain, white; YAP, red. Scale bar=50 µm. Data are represented relative to 0 min (no UTP treatment). *P<0.05 indicates significant difference from 0 min as measured by 1-way ANOVA followed by Dunnett post hoc test.
and pancreatic duct epithelial cells. 46 In addition, P2Y 2 Rinduced migration in hCPCs is consistent with promigratory responses of P2Y 2 R in fibroblasts, 24 salivary 14 and corneal epithelial cells. 13 Whether ex vivo manipulation of hCPCs by UTP preconditioning or P2Y 2 R overexpression improves transplanted hCPC homing, expansion, and overall reparative potential for injured myocardium remains to be assessed. P2Y 2 R was implicated in mediating enhanced proliferation and differentiation after preconditioning of atrial-derived hCPCs with ATP for 30 minutes in vitro and in vivo, 25 but involvement of P2Y 2 R in the ATP-induced responses was not confirmed through any inhibitor, loss-or gain-offunction studies. Additionally, ATP-mediated responses were primarily attributed to stimulating calcium signaling. Results obtained herein demonstrate that UTP-induced proliferative and migratory responses in hCPCs are dependent on YAP activation (Figure 8 ). Despite extensive study of Hippo signaling pathway and the downstream effector YAP, upstream regulatory extracellular signals and their membrane receptors have remained elusive. Recently, 2 independent studies reported that G protein-coupled receptors play a major role in regulating Hippo pathway. 19, 47 Gαq/11-and Gαi/o-coupled signals induce YAP activity, whereas Gαs-coupled signals repress YAP. 20 Concordantly, our data show Gαq protein-coupled P2Y 2 R induces YAP activation ( Figures 3F, 5 , and 6) revealing a novel link between extracellular nucleotides released during injury/stress and Hippo signaling-a core component in mediating CPC proliferation and overall cardiac regeneration. 48 Whether crosstalk occurs between YAP and other signaling molecules acting downstream of P2Y 2 R, such as calcium, growth factor receptors, Arg-Gly-Asp-binding integrins, and Rho GTPases, remains to be determined. Furthermore, involvement of YAP in promoting hCPC proliferation and migration supports previous literature demonstrating similar responses downstream of YAP, as extensively studied in several cancer models [26] [27] [28] [29] [30] where YAP inhibition was proposed as a potential therapeutic target to halt tumorigenesis. Differential expression of P2 purinergic receptors between fast-and slow-growing hCPCs was not restricted to P2Y 2 R. The ADP receptor P2Y 1 (P2Y 1 R) was also significantly downregulated in S-hCPCs compared with F-hCPCs ( Figure 2D ). P2Y 1 R regulates regenerative responses in several tissues. P2Y 1 R mediates chondrocyte proliferation and cartilage repair in osteoarthritis, 49 neuronal fiber outgrowth in organotypic brain slice cocultures, 50 expression of wound healing regulator cyclooxygenase-2 in intestinal subepithelial myofibroblasts 51 in addition to regulating proliferation and repair of retinal tissue in response to cytotoxic injury. 52 The UDP-sugar P2Y 14 receptor (P2Y 14 R) is another interesting target downregulated in S-hCPCs compared with fast-growing cells ( Figure 2H ). Cumulative data during the past decade demonstrate involvement of P2Y 14 R in inducing proliferation and migration of human keratinocytes, 53 chemotaxis of human hematopoietic stem cells, 54 and human neutrophils. 55 In addition, P2Y 14 R enhances mouse hematopoietic stem cell resistance to stress-induced senescence and maintains regenerative capacity after injury. 56 Future studies will aim to assess whether P2Y 1 R and P2Y 14 R mediate proregenerative roles in hCPCs. Overall, establishing physiological responses downstream of individual members of the P2 receptor family represents the first step toward understanding unexplored roles of purinergic signaling in hCPCs. Purinergic receptors with validated proregenerative roles could be used as cell surface markers for initial isolation of hCPCs from tissue specimens of patients with HF to enrich for potentiated stem cells with enhanced responsiveness to purinergic drive in the extracellular environment. Many P2 receptors share common agonists indicates a potential crosstalk among P2 family members in hCPCs, reinforcing the importance of understanding signaling interplay between various P2 receptors.
In summary, the present study demonstrates lack of expression of a subset of P2 purinergic receptors in functionally compromised hCPCs derived from patients with HF. These findings fit with a growing body of supportive studies focused on addressing inherent deficits of cardiac stem cells with the ultimate goal of boosting their phenotypic properties. P2Y 2 R is part of the regulatory network of proliferation and migration responses impaired in CPCs isolated from human patients with HF. Restoration of a youthful phenotype to CPCs, possibly including purinergic signaling, can augment engraftment and survival as noted in previous publications from our laboratory. 21 Our findings can shed light on underlying impairment of endogenous stem cell repair in the aged or pathologically damaged myocardium. Cell proliferation and migration were measured as described in Figure 4 . *P<0.05 indicates significant difference between UTP groups treated vs nontreated with YAP inhibitor as measured by 2-way ANOVA followed by Bonferroni post hoc test.
